Deutsche Bank’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
Other funds holding VTVT
HF
WAG
CIM
Deutsche Bank's VTVT Position: Q2 2021 in Review
Deutsche Bank sold out of vTv Therapeutics (VTVT) in Q2 2021, closing a stake of 159 shares — an estimated $18K sold.
Deutsche Bank first reported a position in VTVT in Q3 2015 and held it in 20 quarters. The position peaked at $187K in Q2 2017. 42 funds tracked by Wall St. Rank hold VTVT as of Q2 2021.
- Deutsche Bank reported no remaining vTv Therapeutics position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 159 vTv Therapeutics shares in Q2 2021, an estimated $18K.
- Deutsche Bank first reported a position in vTv Therapeutics in Q3 2015 and held it in 20 quarters.
- Deutsche Bank's vTv Therapeutics position peaked at $187K in Q2 2017.
- 42 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.